Evernorth to offer Stelara biosimilar at $0 out of pocket for patients early next yearThe estimated savings for individual Accredo patients is around $4,000 per year. Former FDA commissioner Janet Woodcock to headline AAM’s GRx+Biosims conferenceThe conference takes place in Rockland, Md., Oct. 21-23. Beyond lick, stick and pour Meet the pharmacy technology and automation companies that are ensuring pharmacists practice at maximum efficiency so they can provide patient-facing care. A conversation with The Compliance Team’s Sandra Canally The company, celebrating its 30th anniversary, announced a new E-commerce Protection Accreditation for Pharmacy program. Addressing the decline in graduating pharmacists Pharmacist burnout requires strategies that embrace innovative solutions like AI-driven automation. Lupin releases generic Myrbetriq Generic Myrbetriq is used to treat overactive bladder symptoms. NCPA pushes CMS for regulations outlining PBM contracting guardrails NCPA is urging CMS to eliminate abuses by plans and PBMs in Part D and ensure patient access to accurate information. NACDS shares HHS campaign ahead of respiratory virus season The campaign's goal is to increase awareness and uptake of vaccines that reduce severe illness from flu, COVID-19 and RSV in at-risk populations. McKesson to sell Rexall, Well.ca to Birch Hill Equity Partners McKesson said the sale will allow the company to further focus and prioritize investments to grow its oncology and biopharma services platforms. PfizerForAll digital platform makes its debut The platform is intended to support Americans affected annually by common illnesses and those seeking to protect themselves with adult vaccinations. First Previous 18 19 20 21 22 Next Last
